Transition from Trough-Based Dosing to AUC-Based Targets with Vancomycin Drug Monitoring
Fully compliant with the IDSA/ASHP Vancomycin 2020 guidelines, PrecisePK computes drug recommendations based on your therapeutic target (e.g. AUC, peak, trough). Have confidence in the calculations as they are personalized to your patient’s individual PK parameters.
Changeover from In-House Excel Sheets, One-Compartment Online Calculators, and Other Traditional Dosing Techniques
Forget the cluttered, dated and disorganized ways of dosing and instead streamline your everyday workflow with PrecisePK’s user-friendly interface. Save patient cases, build upon existing dosage history, and share patient history with colleagues for easy hand-off and improved coordination of care.
Individualized Dosing for Special Populations and Narrow Therapeutic Conditions
In PrecisePK, all populations are aligned according to the IDSA/ASHP 2020 Vancomycin guidelines, which include:
- Critically Ill
- Obesity
- Pediatric
- Neonatal
- Dialysis
- Adult
Have PrecisePK automatically select the model that best fits your patient, or manually select the model appropriate for your patient.
Instantaneous Results with One Randomly Drawn Serum Drug Level
Input your lab results (e.g. Scr, CrCl, drug level) and receive on-the-spot dosing recommendations. No need to wait until steady state or at trough to draw the blood level. Achieve therapeutic steady states faster and safer with PrecisePK, giving you more time back and saving your pharmacy budget for other resources!
Minimize Rate of Toxicity with a Comprehensive Alert System
Receive toxicity warnings, alternative dosing regimens and drug exposure predictions to provide safer drug therapy. Alerts such as when AUC is outside of recommended range or if your patient is reaching potential ototoxicity state can be used to adjust your dosing practice.
Personalize PrecisePK to Your Current Protocol
Plan ahead effectively by viewing serum levels and drug exposure predictions based on specified dosing regimens. Quickly receive toxicity warnings and evaluate how to help your patients reach therapeutic targets.
Audit & Analyze Data from Your Clinical Decisions, Patient Population, and AKI Status
PrecisePK assists with your institution’s yearly audit by analyzing patient population’s therapeutic statuses, dosing strategies, and AKI incidences. Retroactively compare against past data to confirm your hospital’s dosing practices and track the progress of your patient population.
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
